A Nature Medicine study published June 12, 2026, found that general-purpose frontier chatbots—OpenAI's GPT-5.2, Google's Gemini 3.1 Pro, and Anthropic's Claude Opus 4.6—outperformed specialist clinica…
OpenEvidence, the Miami-based AI platform for healthcare professionals, is reportedly considering raising $200 million at a $20 billion valuation, a nearly 6x increase from its $3.5 billion valuation …
Large language models (LLMs) like those powering ChatGPT and OpenEvidence generate text via next-token prediction without any fact-check step, meaning fluency does not guarantee accuracy, according to…
A study evaluating AI tools on real clinical queries from physicians found that a specialized clinical tool (OpenEvidence) outperformed frontier general-purpose models (Claude Opus 4.8, Gemini 3.1 Pro…
Baseten, an AI inference infrastructure startup, is closing a $1.5 billion funding round that values the company at up to $13 billion, tripling its valuation in six months. The round is co-led by Alti…
General-purpose large language models (LLMs) including GPT-5.2, Gemini 3.1 Pro, and Claude Opus 4.6 outperformed specialized clinical AI tools OpenEvidence and UpToDate Expert AI across three evaluati…
A Nature Medicine paper claiming general-purpose LLMs outperform specialized clinical tools on medical benchmarks is criticized for flawed methodology. The benchmark, Real Clinical Queries, evaluated …
General-purpose large language models GPT-5.2, Gemini 3.1 Pro, and Claude Opus 4.6 outperformed specialized clinical AI tools OpenEvidence and UpToDate Expert AI on medical knowledge tests, expert ali…
A study published June 12, 2026, in Nature Medicine found that general-purpose large language models from OpenAI, Google, and Anthropic outperformed dedicated clinical AI products on medical benchmark…
General-purpose frontier LLMs outperformed two specialized clinical AI tools across medical benchmarks in a Nature Medicine study published June 12. Researchers compared OpenEvidence and UpToDate Expe…
Generative AI is shifting B2B discovery, evaluation, and recommendation into AI-mediated environments that buyers do not control, according to a Harvard Business Review report. The report illustrates …